SEC Form 4 · accession 0001193125-26-385250
Phathom Pharmaceuticals, Inc. · PHAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Charles Breedlove
Officer — Principal Accounting Officer
Period of report
Sep 3, 2026
Accepted (ET)
Sep 8, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001783183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 3, 2026 | F | 460 | $9.05 | D | 59,465 | D | |
| Common Stock | holding | — | — | — | 8,192 | I | By 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation.